Therapy News and Research

RSS

CHOP forms first startup firm to develop treatments for peripheral artery disease

Building on its extensive laboratory research using magnetically guided nanoparticles to deliver drugs to diseased blood vessels, The Children's Hospital of Philadelphia has just spun off its first startup company, Vascular Magnetics, Inc.

10 May 2011

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.

10 May 2011

Research finds 'no safe window' for painkiller use among heart attack survivors

Even short-term use of some painkillers could be dangerous for people who've had a heart attack, according to research published in Circulation: Journal of the American Heart Association.

10 May 2011

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Sucampo Pharmaceuticals, Inc. and Abbott today reported data from a phase 3 clinical efficacy trial in 124 Japanese chronic idiopathic constipation patients as well as from a phase 3 long-term safety trial in an additional 209 Japanese CIC patients.

10 May 2011

Teen alcohol consumption associated with computer use

Teenagers who drink alcohol spend more time on their computers for recreational use, including social networking and downloading and listening to music, compared with their peers who don't drink.

9 May 2011

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Although most commonly associated with military combat, post-traumatic stress disorder (PTSD) can occur in civilians, too - and with consequences that are just as serious, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). PTSD is a type of anxiety disorder that occurs after a person experiences a traumatic event involving physical injury, and occurs in 20 to 51 percent of patients with an orthopaedic injury.

9 May 2011

ImThera Medical concludes Phase I and II protocols for aura6000 European Pilot study in OSA

ImThera Medical, Inc. today announced that it has concluded its Phase I and Phase II protocols for the European Pilot study of the aura6000, a neurostimulation device for treating Obstructive Sleep Apnea (OSA). Clinical trial results from the study will be announced at the American Thoracic Society's International Conference on May 16, 2011 in Denver, CO.

9 May 2011

GTx reports net loss of $2.6 million for first quarter 2011

GTx, Inc. today provided a company update and reported financial results for the first quarter of 2011.

9 May 2011

OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily

OncoSec Medical Inc., a therapeutic oncology company developing innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today the cancer therapy company's tumor-destroying, tissue-sparing drug/device technology was profiled in Medical Device Daily, the news source for the high-tech medical technology industry that is relied on by thousands of industry insiders every business morning.

9 May 2011

Merrimack, PharmaEngine collaborate to develop and commercialize PEP02 in Asia and Europe

PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.

9 May 2011

Psychotherapeutic treatment can cure cyclothymic disorder

In the current issue of Psychotherapy and Psychosomatics a group of Italian investigators headed by Giovanni Fava published a randomized controlled trial on psychotherapeutic treatment of cyclothymic disorder, a disturbance that is characterized by rapid alternation of mood swings.

9 May 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.

9 May 2011

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.

9 May 2011

Preliminary data from ST-DETECT Trial using EGM signals in ICDs presented at SCAI meeting

New data presented today at the Society for Cardiovascular Angiography and Interventions Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators to detect restricted blood flow to the heart in high-risk cardiovascular disease patients outside the hospital setting.

9 May 2011

Philips, IBA enter agreement to establish proton therapy center for patients

IBA Group, a leader in advanced cancer diagnosis and therapy technologies and Royal Philips Electronics, today announced they have entered into an agreement to create state of the art patient-centric proton therapy centers.

From Philips Healthcare 9 May 2011

Diamyd Medical announces European Phase III study results in type 1 diabetes

Diamyd Medical reports that results from its European Phase III study with the antigen-based therapy Diamyd did not meet the primary efficacy endpoint of preserving beta cell function at 15 months, as measured by meal stimulated C-peptide, in newly diagnosed type 1 diabetes patients.

9 May 2011

New international project to create more mutant genes, address shortage of Cre resources

Local scientists are now part of an International team compiling an enormous bank of resources for research into the functions of all known genes. The development of these biological resources will eventually allow scientists to know how the human genome behaves in health and disease.

9 May 2011

Innovative detection practices may prevent liver diseases

Research being presented at Digestive Disease Week- shows that screening individuals for hepatitis C based on age instead of conventional risk factors may help increase detection rates as well as prevent liver disease.

9 May 2011

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Cardiologists from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research at The Heart Rhythm Society's 32nd Annual Scientific Sessions, May 4 -7 in San Francisco, California.

9 May 2011

Breast cancer linked to lifestyle & three new genes

According to the latest research as many as 20,000 British women could avoid developing breast cancer if they took more exercise, drank less and ate better. The World Cancer Research Fund recommends taking half an hour of physical exercise a day, limiting alcohol consumption to just one drink daily and losing weight.

8 May 2011

Therapy News and Research

CHOP forms first startup firm to develop treatments for peripheral artery disease

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

Research finds 'no safe window' for painkiller use among heart attack survivors

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Teen alcohol consumption associated with computer use

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

ImThera Medical concludes Phase I and II protocols for aura6000 European Pilot study in OSA

GTx reports net loss of $2.6 million for first quarter 2011

OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily

Merrimack, PharmaEngine collaborate to develop and commercialize PEP02 in Asia and Europe

Psychotherapeutic treatment can cure cyclothymic disorder

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Preliminary data from ST-DETECT Trial using EGM signals in ICDs presented at SCAI meeting

Philips, IBA enter agreement to establish proton therapy center for patients

Diamyd Medical announces European Phase III study results in type 1 diabetes

New international project to create more mutant genes, address shortage of Cre resources

Innovative detection practices may prevent liver diseases

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Breast cancer linked to lifestyle & three new genes

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News